TG Therapeutics, Inc. (TGTX)
31.57
+0.63
(+2.04%)
USD |
NASDAQ |
Jan 21, 16:00
31.70
+0.13
(+0.41%)
Pre-Market: 09:23
TG Therapeutics Free Cash Flow: -70.24M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 9.691M |
| MannKind Corp. | 42.74M |
| Karyopharm Therapeutics, Inc. | -89.30M |
| Axsome Therapeutics, Inc. | -101.39M |
| Krystal Biotech, Inc. | 165.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.15M |
| Cash from Investing (Quarterly) | 46.36M |
| Cash from Financing (Quarterly) | -78.24M |
| Free Cash Flow Per Share (Quarterly) | -0.1443 |
| Free Cash Flow to Equity (Quarterly) | -23.23M |
| Free Cash Flow to Firm (Quarterly) | 78.17M |
| Free Cash Flow Yield | -1.38% |